RÉSUMÉ
OBJECTIVE: Post transfusion manifestations and its affiliated factors are vital to understand in a disease like hemophilia where multi-transfusions are given to the patients. METHODS: To investigate the implications of factor replacement therapy on plasma proteins, 52 hemophiliacs and 68 carrier females were examined for 12 plasma proteins using various electrophoretic techniques. RESULTS: Severe hemophiliacs showed raised levels ( p< 0.05) of a2 M, IgG and Albumins where values were found to be 4.78 +/- 0.865 g/l, 21.48 +/- 3.38 g/l, 66.26 +/- 11.92 g/l respectively at 95% confidence intervals however, controls and carriers showed trivial variations. CONCLUSION: Juxtaposing the dissimilarities of 12 plasma proteins in carriers, controls and hemophiliacs, it has been gleaned that factor replacement therapy do play role when seen in severe hemophiliacs with raised levels.
Sujet(s)
Anticoagulants/usage thérapeutique , Protéines du sang/analyse , Électrophorèse sur gel d'agar , Facteur VIII/usage thérapeutique , Femelle , Hémophilie A/sang , Humains , Immunoglobuline G/analyse , MâleRÉSUMÉ
In order to study genetic variability of apolipoprotein C-II in Ramgarhias and Ramdasias, two-dimensional gel electrophoresis with the combination of isoelectric focusing (IEF) and density gradient SDS-polyacrylamide gel electrophoresis (DG-SDS-PAGE) have been employed. ApoC-II exhibits three common polymorphic alleles CII-1, CII-2 and CII-3 with pooled frequencies of 0.883, 0.110 and 0.007 respectively. The rare allele CII-4 is absent in these two groups. Mean heterozygosity is found to be 0.208+ 0.024 at apoC-II structural locus. The frequency of apoCII-2 in Punjab is observed to be the highest in the world except Ukainers.